A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis

NCT00203086 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.